3 rd India-Russia Forum on Trade and Investment

1. 3rd India-Russia Forum on Trade and Investment Moscow Hotel Ritz Carlton 29 September 2009 Sandeep Nasa Unique Pharmaceutical Laboratories

2. Global Pharmaceutical Sales, 2001 - 2008 Source: IMS Health Market Prognosis (includes IMS Audited and Unaudited markets) All information current as of March,2009

3. Total Unaudited and Audited Global Pharmaceutical Market by Region Notes on Numbers: All forecast are from IMS Market Prognosis International 2009 – 2013 which provides a view of the audited and unaudited market, using audited sales and adjusting for unaudited sales. The forecasts are based on the March 2009 Market Prognosis release; the next scheduled update is end of October 2009. Source: IMS Health Market Prognosis, March 2009

4. Indian Pharma Profile

5. Current Indian pharma export profile • Export to over 200 destinations • Europe, North America together account for half of exports • Share of dosage exports 52% - a noteworthy achievement • World’s No. 1 Pharma market USA also India’s top destination

6. Government Initiatives for Pharma sector • 100% FDI permitted through Automatic route • Technology freely importable both Lumpsum, Royalty applicable • Foreign Trade policy instruments – Advanced Autorisation, DEPB, EPCG • New moves – Focus Markets • R&D initiatives – funding • In House R&D recognition • Modernization • Registration system streamlined for import of drugs – both site and product registration • Product patents for drugs, food and agrochemicals since 2005

7. For Russian companies opportunities from India: • Bulk Drugs (APLs) • Drug formulations • Biological products • Medicinal plants • Diagnostics • Contract research • Clinical research • Collaborative research • Technologies/consultancy • Drug intermediates • Biotechnology • Herbal products • Homeopathy • Nutraceuticals & Phytochemicals • Contract manufacturing • Surgical dressing • Pharma industry related services • Veterenary drugs

8. Russian Pharma Profile

9. Russian pharma market outlook, 2009-2010 Conservative scenario for 09-10: - 3,7%; - 4,5% Favorable scenario for 09-10: + 4,3%; + 7,7% Source: Pharmexpert calculations

10. Share ratio of imported and local production in CIS markets (1st half year 2009) in value terms Source: Pharmexpert calculations Monitoring of retail and hospital purchases of drugs in CIS countries

11. Russian president highlighted main objectives for pharma market “Pharma market is rapidly developing in many respects to state programs and that money, which came to this sphere. It shows an average of 10 – 12% annual growth rate. According to expert estimations, in 10 years the sales volume of drugs in Russia will reach the level of about 1,5 trillions rubles. This is really a significant figure. In fact we will reach the mid-European level of consumption of drugs, what will in the long rub improve the length of life and its quality. Sales of medical equipment should grow fast as well”. The key is to serve the interests of Russian people and local manufacturers. D.A.Medvedev, speech on the meeting of the Commission of Modernization and Technological Development of Russian economics in Pokrov (Vladimirskaya oblast), 31 August 2009

12. Image of Russia up to 2020 – attractive lifestyle • Comfortable conditions of living • Availability of high-quality of healthcare and educational services • Increase of share of middle class • New vision of Russian regions Concept of social-economic development of Russia till 2020, approved by the Decree of RF Government of November 17th 2008

13. Main objectives of demographic policy of Russia till 2025: Objective Decreasing the rate of people’s natural loss, stabilization of the number of population and creating conditions for its growth, improving the quality of life and increasing its expectancy AIMS • Decline the rate of mortality • Maintenance of people’s health, increasing life expectancy • Increasing birth rate • Managing the process of migration • Protection from emergencies FIGURES • Growth of population of Russia till 2025 up to 145 mln. • Rate of mortality – not higher that 10,8 – 11 • Cumulative birth rate – 1,75 – 1,80 Concept of demographic policy of Russia till 2015, approved by the Decree of President N 1351 of October 9th 2007

14. Hot Russian Pharma Topics 2009 Healthcare Development Concept Till 2020 Federal Law “On the drug circulation” Government Decree “On improvement of state regulation of prices for Essential Drugs” Strategy of Development of Domestic Pharma industry till 2020

15. Main tasks of Healthcare Development Concept till 2020: Objective Providing for accessibility of high-quality health care, its conformity to disease incidence and demand in terms of value, types and technologies Directions • Developing and implementing treatment standards on a wide scale • Making specific the state guarantee program • Implementing a competitive obligatory health insurance model • Population screening, disease prevention • Improving drug provision INDICES • Growth of state expenditures from 3,6% GDP in 2008 to 5,2 – 5,5% • Decreasing mortality from heart and circulation disorders by 1,4 times, from external factors – twofold. Maintaining infant and mother mortality at the rate typical of developed nations Concept of demographic policy of Russia till 2015, approved by the Decree of President N 1351 of October 9th 2007

16. Unique Pharmaceutical Laboratories main brands